Paid Clinical Trials in Duarte, CA

As of September 2026, 546 paid clinical trials are recruiting in Duarte, California. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.

Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 24, 2026.

Filter results

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

508 clinical trials

Get a weekly email when new trials open in Duarte, CA.

BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHL

for Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma

Sites in Duarte, Stanford +4 more locations

Sponsor: PeproMene Bio, Inc.

Sex: All·Age: 18+

Code: NCT05370430·Phase 1·Recruiting·Listed May 2022

Apply to this trial

Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL

for Leukemia, Myeloid, Chronic

Sites in Duarte +7 more locations

Sponsor: Ascentage Pharma Group Inc.

Sex: All·Age: 18+

Code: NCT04260022·Phase 1·Recruiting·Listed Feb 2020

Apply to this trial

A Study Evaluating the Safety and Efficacy of PRV111, PRV211, and PRV131 in Subjects With Oral and Lung Cancers

for Oral Squamous Cell Carcinoma

Sites in Duarte +3 more locations

Sponsor: Privo Technologies

Sex: All·Age: 18 - 100

Code: NCT05893888·Phase 2, Phase 3·Recruiting·Listed Jun 2023

Apply to this trial

Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia

for Relapsed/Refractory Acute Myeloid Leukemia

Sites in Duarte +5 more locations

Sponsor: Nerviano Medical Sciences

Sex: All·Age: 18+

Code: NCT06549790·Phase 1·Recruiting·Listed Aug 2024

Apply to this trial

A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases

for Recurrent Head and Neck Squamous Cell Carcinoma

Sites in Duarte +6 more locations

Sponsor: Rakuten Medical, Inc.

Sex: All·Age: 18+

Code: NCT06699212·Phase 3·Recruiting·Listed Nov 2024

Apply to this trial

Safety of MT-401-OTS in Patients With Relapsed AML or MDS

for Acute Myeloid Leukemia, in Relapse

Sites in Duarte +2 more locations

Sponsor: Marker Therapeutics, Inc.

Sex: All·Age: 65+

Code: NCT06552416·Phase 1·Recruiting·Listed Aug 2024

Apply to this trial

A Dose Randomization Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated With ADCs

for Triple Negative Breast Cancer

Sites in Duarte, La Jolla +4 more locations

Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd.

Sex: All·Age: 18+

Code: NCT06908928·Phase 1·Recruiting·Listed Apr 2025

Apply to this trial

A Long Term Follow-up Study of TScan TCR-T Products

for AML

Sites in Duarte +1 more location

Sponsor: TScan Therapeutics, Inc.

Sex: All·Age: 18 - 110

Code: NCT06976736·Recruiting·Listed May 2025

Apply to this trial

A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes

for Acute Myeloid Leukemia

Sites in Duarte +2 more locations

Sponsor: GluBio Therapeutics Inc.

Sex: All·Age: 18+

Code: NCT06146257·Phase 1·Recruiting·Listed Nov 2023

Apply to this trial

CBM588 Capsules in Combination With Nivolumab and Ipilimumab for the Treatment of Advanced Stage Kidney Cancer

for Advanced Clear Cell Renal Cell Carcinoma

Drug: Ipilimumab

1 location in Duarte

Sponsor: Osel, Inc.

Sex: All·Age: 18+

Code: NCT06399419·Phase 1·Recruiting·Listed May 2024

Apply to this trial

Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy System

for Cancer

Sites in Duarte, Palo Alto +3 more locations

Sponsor: RefleXion Medical

Sex: All·Age: All ages

Code: NCT05406167·Recruiting·Listed Jun 2022

Apply to this trial

Phase 1b/2a Randomized Double-blind Study to Investigate Safety Tolerability PK PD Preliminary Efficacy of Oral Administration of SNIPR001 in Patients With Hematologic Malignancy Scheduled for Allogeneic Hematopoietic Stem-Cell Transplant Receiving FQ Prophylaxis & Harboring FQR Ecoli Pre-Transplant

for E Coli Infections

Sites in Duarte, San Francisco +6 more locations

Sponsor: SNIPR Biome Aps.

Sex: All·Age: 18+

Code: NCT06938867·Phase 1, Phase 2·Recruiting·Listed Apr 2025

Apply to this trial

A Study of Tegavivint (BC2059) in Patients With Advanced Hepatocellular Carcinoma

for Advanced Hepatocellular Carcinoma

Sites in Duarte +6 more locations

Sponsor: Iterion Therapeutics

Sex: All·Age: 18+

Code: NCT05797805·Phase 1, Phase 2·Recruiting·Listed Apr 2023

Apply to this trial

Study of APG-2575 as a Single Agent or in Combination With Other Therapeutic Agents for CLL/SLL

for CLL/SLL

Sites in Duarte +6 more locations

Sponsor: Ascentage Pharma Group Inc.

Sex: All·Age: 18 - 85

Code: NCT04215809·Phase 1·Recruiting·Listed Jan 2020

Apply to this trial

This is a Study to Evaluate the Safety and Tolerability of ABL503, and to Determine the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D) of ABL503 in Subjects with Any Progressive Locally Advanced or Metastatic Solid Tumors

for Advanced Solid Tumor

Sites in Duarte, Los Angeles +3 more locations

Sponsor: ABL Bio, Inc.

Sex: All·Age: 18+

Code: NCT04762641·Phase 1·Recruiting·Listed Feb 2021

Apply to this trial

64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer

for Metastatic Sarcoma

Sites in Duarte, Orange +3 more locations

Sponsor: Lantheus Medical Imaging

Sex: All·Age: 15+

Code: NCT06298916·Phase 1, Phase 2·Recruiting·Listed Mar 2024

Apply to this trial

Study of SIRPant-M in Participants With Relapsed or Refractory Non-Hodgkin's Lymphoma

for Refractory Non-Hodgkin Lymphoma

Sites in Duarte +2 more locations

Sponsor: SIRPant Immunotherapeutics, Inc.

Sex: All·Age: 18+

Code: NCT05967416·Phase 1·Recruiting·Listed Aug 2023

Apply to this trial

A First-in-human (FIH), Phase I Study of PTX-912 in Patients with Locally Advanced/Metastatic Solid Tumors

for Advanced Cancer

Sites in Duarte +2 more locations

Sponsor: Proviva Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06190886·Phase 1·Recruiting·Listed Jan 2024

Apply to this trial

Study of REM-422 in Patients With AML or Higher Risk MDS

for Myelodysplastic Syndromes

Sites in Duarte +4 more locations

Sponsor: Remix Therapeutics

Sex: All·Age: 18+

Code: NCT06297941·Phase 1·Recruiting·Listed Mar 2024

Apply to this trial

A Study of ADRX-0405 in Subjects With Select Advanced Solid Tumors

for Solid Tumors

Sites in Duarte, Santa Monica +6 more locations

Sponsor: Adcentrx Therapeutics

Sex: All·Age: 18+

Code: NCT06710379·Phase 1·Recruiting·Listed Nov 2024

Apply to this trial

Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)

for Hematologic Malignancy

Sites in Duarte +4 more locations

Sponsor: Tr1X, Inc.

Sex: All·Age: 18+

Code: NCT06462365·Phase 1·Recruiting·Listed Jun 2024

Apply to this trial

Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer

for Colorectal Neoplasms

Sites in Duarte, La Jolla +4 more locations

Sponsor: Surgimab

Sex: All·Age: 18+

Code: NCT03659448·Phase 3·Recruiting·Listed Sep 2018

Apply to this trial

A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

for Acute Myeloid Leukemia

Sites in Duarte +2 more locations

Sponsor: Edgewood Oncology Inc.

Sex: All·Age: 18+

Code: NCT04243785·Phase 1·Recruiting·Listed Jan 2020

Apply to this trial

Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)

for Metastatic Breast Cancer

1 location in Duarte

Sponsor: Minerva Biotechnologies Corporation

Sex: All·Age: 18+

Code: NCT04020575·Phase 1·Recruiting·Listed Jul 2019

Apply to this trial

Individualized AML Treatment

for Relapsed/Refractory Acute Myeloid Leukemia (AML)

1 location in Duarte

Sponsor: City of Hope Medical Center

Sex: All·Age: 18+

Code: NCT07613385·Recruiting·Listed May 2026

Apply to this trial

Investigating the Feasibility and Acceptability of an Innovative Interdisciplinary Supportive Care Program: Couples Coping Together Against Cancer

for Anatomic Stage IV Breast Cancer AJCC v8

1 location in Duarte

Sponsor: City of Hope Medical Center

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT07664579·Recruiting·Listed Jun 2026

Apply to this trial

Fluorescence-Guided Surgical Resection for Reducing Unexpected Positive Margins in Patients With Sarcoma, SarcoSIGHT Trial

for High Grade Sarcoma

1 location in Duarte

Sponsor: City of Hope Medical Center

Sex: All·Age: All ages

Code: NCT07650656·Phase 2·Recruiting·Listed Jun 2026

Apply to this trial

Neoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable Colorectal Cancer NEST3

for Advanced Colon Adenocarcinoma

Drug: Botensilimab

Sites in Duarte, South Pasadena +9 more locations

Sponsor: City of Hope Medical Center

Sex: All·Age: 18+

Code: NCT07595874·Phase 2·Recruiting·Listed May 2026

Apply to this trial

Locoregional Administration of Genetically Engineered Cells (EGFR/IL13Rα2 Pool-CAR T Cells) for the Treatment of Recurrent or Progressive High-Grade Gliomas

for Recurrent Astrocytoma, IDH-Mutant, Grade 4

1 location in Duarte

Sponsor: City of Hope Medical Center

Sex: All·Age: 18+

Code: NCT07544992·Phase 1·Recruiting·Listed Apr 2026

Apply to this trial

Alternative Splicing Based Prediction of Chemotherapy Response in Gastric Cancer

for Gastric Cancer

1 location in Duarte

Sponsor: City of Hope Medical Center

Sex: All·Age: 18+

Code: NCT07587229·Recruiting·Listed May 2026

Apply to this trial

A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia

for Acute Lymphoblastic Leukemia

Sites in Duarte, Stanford +7 more locations

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 40+

Code: NCT07400029·Phase 2·Recruiting·Listed Feb 2026

Apply to this trial

Epcoritamab, Rituximab, Gemcitabine and Oxaliplatin (R-GemOx) as Salvage Therapy Before Autologous Stem Cell Transplant for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

for Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

Drug: Epcoritamab

Sites in Duarte +2 more locations

Sponsor: City of Hope Medical Center

Sex: All·Age: 18+

Code: NCT07365306·Phase 2·Recruiting·Listed Jan 2026

Apply to this trial

Testing the Effect of Teclistamab on Recurrent Plasmablastic Lymphoma

for Recurrent Plasmablastic Lymphoma

Drug: Teclistamab

Sites in Duarte, Orange +3 more locations

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT07332507·Phase 1·Recruiting·Listed Jan 2026

Apply to this trial

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

for Stage III Colon Cancer

Sites in Duarte, Baldwin Park +923 more locations

Sponsor: NRG Oncology

Sex: All·Age: 18+

Code: NCT05174169·Phase 2, Phase 3·Recruiting·Listed Dec 2021

Apply to this trial

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

for Chronic Lymphocytic Leukemia

Sites in Duarte, Baldwin Park +290 more locations

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT04269902·Phase 3·Recruiting·Listed Feb 2020

Apply to this trial

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

for Anatomic Stage II Breast Cancer AJCC v8

Drug: Durvalumab

Sites in Duarte, Pasadena +535 more locations

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT06058377·Phase 3·Recruiting·Listed Sep 2023

Apply to this trial

Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer

for Astrocytoma, IDH-Mutant, Grade 3

Drug: Vorasidenib

Sites in Duarte, Orange +115 more locations

Sponsor: Alliance for Clinical Trials in Oncology

Sex: All·Age: 12+

Code: NCT07215910·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

for Clear Cell Renal Cell Carcinoma

Sites in Duarte, Upland +401 more locations

Sponsor: Alliance for Clinical Trials in Oncology

Sex: All·Age: 18+

Code: NCT06661720·Phase 3·Recruiting·Listed Oct 2024

Apply to this trial

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer

for Locally Advanced Cervical Adenocarcinoma

Sites in Duarte, South Pasadena +318 more locations

Sponsor: National Cancer Institute (NCI)

Sex: Female·Age: 18+

Code: NCT07061977·Phase 3·Recruiting·Listed Jul 2025

Apply to this trial

Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

for Classic Follicular Lymphoma

Drug: Mosunetuzumab

Sites in Duarte, South Pasadena +258 more locations

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT06337318·Phase 3·Recruiting·Listed Mar 2024

Apply to this trial